Riders For The Cure - Working to Cure Cancer

  • Increase font size
  • Default font size
  • Decrease font size
Previous Rides

Ride For Life 2013

Event Date: June 1, 2013

Ride For Life, a police-escorted motorcycle ride, took place Saturday, June 1, 2013. The ride started and ended at Stubbs Harley-Davidson in Houston on Telephone Road. Thank you to everyone who participated in this very successful ride.

This event supports Anderson Network’s annual patient and caregiver conference held in September. The ride is one of many events commemorating National Cancer Survivor’s Day at MD Anderson during the week of June 1-6. National Cancer Survivor’s Day is held annually on the first Sunday in June in hundreds of communities worldwide to celebrate survivors and their caregivers.

View Ride for Life 2013 Flyer

View The Route and Safety Tips

Video from the Ride for Life 2013

 

Sam's Jam V 2012

Event Date: October 13, 2012

Our fifth annual ride benefiting The University of Texas MD Anderson Cancer Center took place on October 13th, 2012. The event is named Sam’s Jam V after one of the founding members of Riders for the Cure, the Employee Motorcycle group of MD Anderson Cancer Center.

Sam’s Jam: Celebrates the life and work of co-founding member Dr. Samuel Hassenbusch, M.D., Ph.D. “Dr. Sam”, as he was known, was a world-renowned neurosurgeon and researcher who lost his battle with glioblastoma multiforme in 2008. Sam’s Jam honors his spirit, his vitality and most of all, his commitment to patient care and research. Generally held on the second Saturday in October, the day features a police-escorted ride to a local venue featuring live music, unique vendors, and entertainment.


This event funds brain cancer research and the current study is:

Phase I/II study of reirradiation of recurrent or progressive brainstem glioma: This study investigates the use of re-irradiation in the highly aggressive form of cancer known as brainstem glioma. This Phase I/II study will be conducted to evaluate the safety of re-irradiation with higher doses. The main goal of treatment will be to improve symptoms and quality of life. This protocol may identify the optimal dose of re-irradiation and define the efficacy, particularly regarding quality of life, therefore offering a treatment option for patients with an incurable disease. Principal Investigator: Anita Mahajan, M.D.

View Sam's Jam 2012 Flyer

 

Ride For Life 2012

Event Date: June 2, 2012

 


Page 2 of 5

Upcoming Rides

CANCELLED - Ride for Life 2016:

June 4, 2016

Due to the current weather in Houston and with safe considerations, the 2016 Ride for Life is being cancelled.

MyCancerConnection

Ride for Life, a police-escorted motorcycle ride, will take place on in June 4, 2016. The ride will start and end at Stubbs Harley-Davidson in Houston on Telephone Road. Please mark your calendar for this event. The start time (Kick Stands Up) is 10:00am with on-site registration starting at 9:00am.

This event supports MyCancerConnection’s annual patient and caregiver conference held in September. The ride is one of many events commemorating National Cancer Survivor’s Day at MD Anderson. National Cancer Survivor’s Day is held annually on the first Sunday in June in hundreds of communities worldwide to celebrate survivors and their caregivers.

Meetup Facebook

Studies Currently Supported...

STUDIES SUPPORTED

Understanding radiation sensitivity through genetic analysis in Glioblastoma and Central Nervous System Cancers:

 

When a cancer patient receives radiation as part of treatment, there can be significant effects upon their quality of life.  This study is based on using genetic analysis to understand the relationship of radiation and possible genetic factors that could influence outcomes.  Better understanding of the genetic factors that lead to patients being more or less sensitive to radiation will help improve treatment and thus the quality of life for the patients.  The effects of radiation can lead to a decline in mental abilities and thus understanding possible genetic factors can help the medical team create a personalized cancer therapy to improve the quality of life, especially in brain tumor patients.

 

Principle Investigator: Erik P. Sulman, M.D., Ph.D., The University of Texas MD Anderson Cancer Center.